Nathan Schneiderman, an analyst with Roth Capital, reports in a research note this morning that the company forecast revenue for the current year of $855 million to $865 million, with EPS of $1.70-$1.75 a share. The Street consensus has been for $854 million and $1.71 a share. Schneiderman wrote today that the revised guidance was “the highlight” of Friday’s meeting. He maintains a Buy rating and $42 price target on the stock.
Jason Maynard, an analyst at Credit Suisse, today raised his 2007 EPS forecast to $1.73 from $1.69, consistent with the new guidance, and increased his price target for the company to $37 from $34. He remains Neutral on the stock, though. He notes that specualation about consolidation in the business intelligent segment should keep a floor on the stock in the low $30 range.
Steven Ashley, an analyst at Robert W. Baird, today confirmed his Outperform rating and $40 price target, but increased his estimates to $1.72 from $1.70 for this year and to $1.94 from $1.90 for fiscal 2008.
Keith Weiss, at Morgan Stanley, asserts that “investors are underestimating both the potential of Hyperion’s expanded product line to capture incremental demand and the strategic value of Hyperion’s strategic positioning with the finance department.” He rates the stock Overweight, with a $50 price target.
Edward Maguire, at Merrill Lynch, maintained his Buy rating and $42 price target on the stock, but increased estimates. He went to $1.73 a share for this year from $1.70. For fiscal ‘08, he went to $1.95 from $1.92.
Hyperion today is up 96 cents at $38.36.